Molecular basis for gating of cardiac ryanodine receptor explains the mechanisms for gain- and loss-of function mutations

  • Kobayashi, Takuya
    Department of Cellular and Molecular Pharmacology, Juntendo University Graduate School of Medicine
  • Tsutsumi, Akihisa
    Department of Cell Biology and Anatomy, Graduate School of Medicine, The University of Tokyo
  • Kurebayashi, Nagomi
    Department of Cellular and Molecular Pharmacology, Juntendo University Graduate School of Medicine
  • Saito, Kei
    Department of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo
  • Kodama, Masami
    Department of Cellular and Molecular Pharmacology, Juntendo University Graduate School of Medicine
  • Sakurai, Takashi
    Department of Cellular and Molecular Pharmacology, Juntendo University Graduate School of Medicine
  • Kikkawa, Masahide
    Department of Cell Biology and Anatomy, Graduate School of Medicine, The University of Tokyo
  • Murayama, Takashi
    Department of Cellular and Molecular Pharmacology, Juntendo University Graduate School of Medicine
  • Ogawa, Haruo
    Department of Structural Biology, Graduate School of Pharmaceutical Sciences, Kyoto University

Abstract

Cardiac ryanodine receptor (RyR2) is a large Ca²⁺ release channel in the sarcoplasmic reticulum and indispensable for excitation-contraction coupling in the heart. RyR2 is activated by Ca²⁺ and RyR2 mutations are implicated in severe arrhythmogenic diseases. Yet, the structural basis underlying channel opening and how mutations affect the channel remains unknown. Here, we address the gating mechanism of RyR2 by combining high-resolution structures determined by cryo-electron microscopy with quantitative functional analysis of channels carrying various mutations in specific residues. We demonstrated two fundamental mechanisms for channel gating: interactions close to the channel pore stabilize the channel to prevent hyperactivity and a series of interactions in the surrounding regions is necessary for channel opening upon Ca²⁺ binding. Mutations at the residues involved in the former and the latter mechanisms cause gain-of-function and loss-of-function, respectively. Our results reveal gating mechanisms of the RyR2 channel and alterations by pathogenic mutations at the atomic level.

Journal

Citations (1)*help

See more

References(50)*help

See more

Related Projects

See more

Details 詳細情報について

Report a problem

Back to top